Phase 2 Randomized Bivalent RSVpreF Maternal Vaccine Trial: Final Safety, Antibody Persistence and Efficacy. Simoes EAF, Madhi SA, Center KJ, Tita ATN, et al. J Infect Dis 2026 Jul 23:jiag378. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Simoes EAF, Madhi SA, Center KJ, Tita ATN, et al. Phase 2 Randomized Bivalent RSVpreF Maternal Vaccine Trial: Final Safety, Antibody Persistence and Efficacy. J Infect Dis 2026 Jul 23:jiag378. doi: 10.1093.
PMID: 42486480